MX2011007639A - Compuestos de carboxamida y metodos para usar los mismos. - Google Patents

Compuestos de carboxamida y metodos para usar los mismos.

Info

Publication number
MX2011007639A
MX2011007639A MX2011007639A MX2011007639A MX2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A MX 2011007639 A MX2011007639 A MX 2011007639A
Authority
MX
Mexico
Prior art keywords
methods
carboxamide compounds
same
compound
disclosed
Prior art date
Application number
MX2011007639A
Other languages
English (en)
Inventor
Rajinder Singh
Hui Hong
Xiang Xu
Ihab S Darwish
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of MX2011007639A publication Critical patent/MX2011007639A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

La presente invención describe compuestos de carboxamida, así como composiciones farmacéuticas y métodos de uso. Una modalidad es un compuesto que tiene la estructura (I), en donde R1, R2 R3, R4, T, p, q, w y x son como se describe en la presente. En ciertas modalidades, un compuesto descrito en la presente activa la trayectoria AMPK, y se puede usar para tratar trastornos y condiciones relacionados al metabolismo.
MX2011007639A 2009-01-28 2010-01-28 Compuestos de carboxamida y metodos para usar los mismos. MX2011007639A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14798209P 2009-01-28 2009-01-28
PCT/US2010/022411 WO2010088392A1 (en) 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same

Publications (1)

Publication Number Publication Date
MX2011007639A true MX2011007639A (es) 2011-09-15

Family

ID=42061132

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007639A MX2011007639A (es) 2009-01-28 2010-01-28 Compuestos de carboxamida y metodos para usar los mismos.

Country Status (18)

Country Link
US (2) US8362235B2 (es)
EP (1) EP2391616B1 (es)
JP (1) JP5658688B2 (es)
KR (1) KR101693061B1 (es)
CN (1) CN102365275B (es)
AU (1) AU2010208247B2 (es)
BR (1) BRPI1007287B8 (es)
CA (1) CA2750835C (es)
EA (1) EA022083B1 (es)
ES (1) ES2581678T3 (es)
HK (1) HK1164860A1 (es)
IL (1) IL214203A (es)
MX (1) MX2011007639A (es)
NZ (1) NZ594556A (es)
SG (1) SG172974A1 (es)
UA (1) UA106600C2 (es)
WO (1) WO2010088392A1 (es)
ZA (1) ZA201105215B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds
AU2011283684B2 (en) 2010-07-29 2015-08-27 Rigel Pharmaceuticals, Inc. AMPK-activating heterocyclic compounds and methods for using the same
US9005909B2 (en) 2011-01-06 2015-04-14 Rigel Pharmaceuticals, Inc. Whole blood assay for measuring AMPK activation
WO2013116491A1 (en) 2012-02-01 2013-08-08 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds and methods for using them
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ａｍｐｋを活性化させるインダゾール化合物
US20150087673A1 (en) * 2013-09-26 2015-03-26 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
JP6664632B2 (ja) 2013-09-30 2020-03-13 国立大学法人 東京大学 アディポネクチン受容体活性化化合物
KR20200119807A (ko) 2018-01-11 2020-10-20 켄타우루스 테라퓨틱스 질병 치료를 위한 디하이드로세라마이드 불포화화효소의 저해제

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
KR100579792B1 (ko) * 1998-05-13 2006-05-12 동화약품공업주식회사 신규 2,5-피리딘디카복실산 유도체
JP2004509891A (ja) * 2000-09-22 2004-04-02 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗糖尿病薬としてのピラゾロピリジンおよびピラゾロピリダジン
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
JP2009521445A (ja) * 2005-12-21 2009-06-04 シェーリング コーポレイション Ｈ３アンタゴニスト／逆アゴニストと食欲抑制剤との組み合わせ
EP1932834B1 (en) 2006-12-11 2011-04-27 The Genetics Company, Inc. Aromatic 1,4-DI-Carboxylamides and their use
CA2674237C (en) 2006-12-28 2015-11-24 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
GB0706793D0 (en) * 2007-04-05 2007-05-16 Evotec Ag Compounds
CN101910131B (zh) 2007-11-16 2014-04-23 里格尔药品股份有限公司 甲酰胺、磺酰胺和胺化合物及其使用方法
WO2009076631A1 (en) * 2007-12-12 2009-06-18 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
US8796254B2 (en) 2010-03-31 2014-08-05 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds

Also Published As

Publication number Publication date
US8846600B2 (en) 2014-09-30
WO2010088392A1 (en) 2010-08-05
CN102365275B (zh) 2014-09-24
BRPI1007287B8 (pt) 2021-05-25
CA2750835A1 (en) 2010-08-05
IL214203A (en) 2015-01-29
EA022083B1 (ru) 2015-10-30
SG172974A1 (en) 2011-08-29
EA201170979A1 (ru) 2012-02-28
JP5658688B2 (ja) 2015-01-28
JP2012516349A (ja) 2012-07-19
IL214203A0 (en) 2011-08-31
AU2010208247B2 (en) 2015-06-18
ES2581678T3 (es) 2016-09-06
ZA201105215B (en) 2012-09-26
AU2010208247A1 (en) 2011-08-11
EP2391616A1 (en) 2011-12-07
US8362235B2 (en) 2013-01-29
CA2750835C (en) 2018-09-04
US20100190802A1 (en) 2010-07-29
NZ594556A (en) 2013-11-29
KR20110119755A (ko) 2011-11-02
US20130131078A1 (en) 2013-05-23
BRPI1007287B1 (pt) 2021-03-09
EP2391616B1 (en) 2016-03-30
HK1164860A1 (zh) 2012-09-28
UA106600C2 (uk) 2014-09-25
KR101693061B1 (ko) 2017-01-04
CN102365275A (zh) 2012-02-29

Similar Documents

Publication Publication Date Title
MX2010005298A (es) Compuestos de carboxamida, sulfonamida y amina para trastornos metabolicos.
MX2011007639A (es) Compuestos de carboxamida y metodos para usar los mismos.
MX338707B (es) Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos.
MX336381B (es) Boronatos como inhibidores de arginasa.
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
MA33776B1 (fr) Dérivés arylecarbonyle et hétéroarylcarbonyle d'hexahydroindénopyridine et d'octahydrobenzoquinoline
MA32393B1 (fr) Composés et compositions servant d'inhibiteurs de kinases
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
EA201100503A1 (ru) Глюкозидные производные и их применения
GB0625648D0 (en) Compounds
JO3025B1 (ar) الأندازولات المستبدلة بالأوكسازول كمثبطات كيناز pi3
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
EA201071231A1 (ru) Карбоксамидные соединения для лечения метаболических растройств
GEP20227397B (en) Inhibitors of influenza viruses replication
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
UA109037C2 (uk) Триазолопіридини
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
MX2011013884A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
TN2013000529A1 (en) Trpm8 antagonists and their use in treatments
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
MX2011008360A (es) Derivados de piridazinona sustituida con heteroarilo.
MX2010004498A (es) Derivados de ciclohexenoamida y su uso como antagonistas de trpv1.

Legal Events

Date Code Title Description
FG Grant or registration